Epstein Secrets

.com/article/us-health-coronavirus-usa-congress/congressional-covid-19- impasse-continues-pelosi-warns-house-is-burning-down-idUSICEIN27S2P6> (11/12, Cornwell) quotes McConnell as saying, "I gather she and the Democratic leader in the Senate still are looking at something dramatically larger. That's not a

www.reuters.cotn/article/us-usa- election/republicans-urge-trump-to-allow-biden-briefings-as-u-s-election-challenges-sputter-idUSICBN27S0LV> (11/12, Cornwell, Chiacu, Lewis), the Washington Times <https://www.washingtontimes.com/news/2020/nov/12/joe-biden-should-start-getting-access-intel-senate/> (11/12

receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."

still believes a bill of about $500 billion is the way to go, even though Senate Democrats have repeatedly rejected his proposal." Reuters (11/12, Cornwell) quotes McConnell as saying, "I gather she and the Democratic leader in the Senate still are looking at something dramatically larger. That's not a

, Arias, 521K), the Wall Street Journal (11/12, Peterson, Wise, Subscription Publication, 7.57M), Bloomberg (11/12, Dennis, 4.73M), Reuters (11/12, Cornwell, Chiacu, Lewis), the Washington Times (11/12, Sherfinski, Meier, 492K), and NPR (11/12, Grisales, 3.12M), among others. Meanwhile, according to the

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fight the virus."

the Wall Street Journal (11/12, Peterson, Wise, Subscription Publication, 7.57M), Bloomberg (11/12, Dennis, 4.73M), EFTA00148405 Reuters (11/12, Cornwell, Chiacu, Lewis), the Washington Times (11/12, Sherfinski, Meier, 492K), and NPR (11/12, Grisales, 3.12M), among others. Meanwhile, according to the

t receiving FDA emergency use authorization just this week, working to speed up the recovery in some of the most vulnerable patients." Correspondent Alex Perez said EFTA00148420 researchers took "the most powerful antibody from one of the first survivors and [are] using a synthetically-made version to fi